Biogen Inc.

Healthcare

NASDAQ:BIIB · NASDAQ Global Select

Market Cap $29.33B Beta 0.18 P/E (TTM) 21.1

$196.58 -1.11%

-$2.21 today

52W Low $121.05High $205.97

Vol 1.45M · Avg 1.17M

EPS (TTM) $9.32Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+57.57%

Period High

$204.53

Period Low

$122.68

Latest

$196.58

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Teva Pharmaceutical Industries Limited

NYSE:TEVA

$36.63B

DexCom, Inc.

NASDAQ:DXCM

$27.85B

Waters Corporation

NYSE:WAT

$23.19B

United Therapeutics Corporation

NASDAQ:UTHR

$22.95B

Quest Diagnostics Incorporated

NYSE:DGX

$21.49B

Labcorp Holdings Inc.

NYSE:LH

$20.95B

STERIS plc

NYSE:STE

$19.66B

Incyte Corporation

NASDAQ:INCY

$19.53B

Genmab A/S

NASDAQ:GMAB

$15.54B

Insulet Corporation

NASDAQ:PODD

$10.01B

What is the latest BIIB filing?

The latest filing shown is 4 dated Jun 11, 2026.

How many recent filings does BIIB have?

Intrinsic Alpha currently shows 20 recent filings for BIIB.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.